Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Other financing activities of $32.9 million for Q1 2026, up 186.09% year-over-year from $11.5 million in Q1 2025, and down 61.38% quarter-over-quarter from $85.2 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Other financing activities history runs 15 years deep, the most recent figure standing at $32.9 million for Q1 2026.
- In Q1 2026, Other financing activities rose 186.09% year-over-year to $32.9 million; the TTM figure through Mar 2026 stood at $129.3 million (up 308.38% YoY), while the FY2025 annual figure was $107.9 million, up 422.41% from the prior year.
- Other financing activities for Q1 2026 stood at $32.9 million, down from $85.2 million in the prior quarter.
- The five-year high for Other financing activities was $85.2 million in Q4 2025, with the low at $17000.0 in Q3 2024.
- The 5-year median for Other financing activities is $10.9 million (2024), against an average of $18.0 million.
- The sharpest annual moves came in 2024 and 2025: Other financing activities sank 99.69% in 2024, then surged 4211.76% in 2025.
- Jazz Pharmaceuticals' Other financing activities stood at $30.2 million in 2022, then slumped by 70.64% to $8.9 million in 2023, then grew by 3.87% to $9.2 million in 2024, then surged by 826.34% to $85.2 million in 2025, then plunged by 61.38% to $32.9 million in 2026.
- Business Quant data shows JAZZ's Other financing activities at $32.9 million in Q1 2026, $85.2 million in Q4 2025, and $733000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.70 Mn |
| Jun 30, 2026 | 22.70 Mn |
| Mar 31, 2026 | 32.90 Mn |
| Mar 31, 2026 | 32.90 Mn |
| Dec 31, 2025 | 85.19 Mn |
| Dec 31, 2025 | 85.19 Mn |
| Sep 30, 2025 | 733,000.00 |
| Sep 30, 2025 | 733,000.00 |
| Jun 30, 2025 | 10.44 Mn |
| Jun 30, 2025 | 10.44 Mn |
| Mar 31, 2025 | 11.50 Mn |
| Mar 31, 2025 | 11.50 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 10.94 Mn |
| Jun 30, 2024 | 10.94 Mn |
| Mar 31, 2024 | 494,000.00 |
| Mar 31, 2024 | 494,000.00 |